Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval symbols : GSK save search
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio
Published: 2023-03-10 (Crawled : 23:00) - prnewswire.com
AMGN | News | $272.245 0.12% 220K
|
Health Technology
| Email alert
Add to watchlist
CTIC | $9.09 0.05% 11M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 630
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $169.965 1.24% 890K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.12 3.15% 1.1M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.865 0.68% 320K
|
Health Technology
| Email alert
Add to watchlist
ADCT | $4.99 6.62% 82K
|
Health Technology
| Email alert
Add to watchlist
approval therapeutics growth market
US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer
Published: 2023-02-10 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -2.43%
H: 0.66%
C: 0.66%
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: -1.07%
H: 0.06%
C: -0.55%
ANAB | $20.27 3.1% 37K
|
Health Technology
|
| O: 0.04%
H: 1.27%
C: -0.62%
treatment fda grants approval cancer
Neurologic Disorders Therapeutics Market Size to Grow by USD 33.46 billion, Approval Of Novel Drugs to Boost Market Growth - Technavio
Published: 2022-08-03 (Crawled : 04:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -1.8%
H: 0.2%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -2.6%
H: 0.0%
C: -0.76%
NPCE | $14.295 2.11% 69K
|
Manufacturing
|
| O: 0.52%
H: 3.71%
C: -2.93%
NVS | News | $98.12 3.15% 1.1M
|
Health Technology
|
| O: 0.11%
H: 0.31%
C: -0.34%
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: -0.29%
H: 0.24%
C: -0.58%
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
SNY | News | $47.375 0.48% 300K
|
Health Technology
|
| O: -0.17%
H: 0.12%
C: -1.29%
BIIB | $194.76 0.34% 110K
|
Health Technology
|
| O: 0.41%
H: 3.35%
C: 1.71%
ACAD | News | $16.99 110K
|
Health Technology
|
| O: 2.47%
H: 2.8%
C: -2.67%
approval therapeutics growth market
GSK Announces US FDA Approval of Benlysta (Belimumab) for Pediatric Patients With Active Lupus Nephritis
Published: 2022-07-27 (Crawled : 20:00) - biospace.com/
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: -0.56%
H: 3.36%
C: 2.98%
fda active lupus approval
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published: 2022-06-03 (Crawled : 06:00) - biospace.com/
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: -0.4%
H: 4.05%
C: -1.35%
PFE | News A | $26.32 0.23% 4.4M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
BMY | $49.35 0.43% 1.4M
|
Health Technology
|
| O: -1.4%
H: 0.0%
C: 0.0%
SNY | News | $47.375 0.48% 300K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
NBIX | News M | $141.21 5.65% 490K
|
Health Technology
|
| O: 2.29%
H: 0.0%
C: 0.0%
AZN | News | $70.47 0.49% 990K
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
lipodystrophy treatment research system active services report service growing hiv profitable hypertension genomics expected virus approval cancer growth group market breast cancer infections
Global Pharmaceutical API Manufacturing Market Report 2022-2030: Stringent Regulations for Approval of Pharmaceutical Drugs Restraining Growth
Published: 2022-04-12 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: -0.86%
H: 1.21%
C: 1.21%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 0.16%
H: 0.22%
C: 0.22%
NVS | News | $98.12 3.15% 1.1M
|
Health Technology
|
| O: -0.48%
H: 0.09%
C: -0.68%
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -0.77%
H: 0.99%
C: 0.49%
ALB | News | $114.435 1.91% 460K
|
Process Industries
|
| O: 1.31%
H: 2.06%
C: -1.76%
ABBV | News | $169.965 1.24% 890K
|
Health Technology
|
| O: -0.31%
H: 0.74%
C: -1.18%
SNY | News | $47.375 0.48% 300K
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
AZN | News | $70.47 0.49% 990K
|
Health Technology
|
| O: -2.32%
H: 0.43%
C: -0.55%
report approval growth market drug
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Virologically Suppressed Adolescents Living With HIV Who Are 12 Years of Age or Older and Weigh at Least 35 kg
Published: 2022-03-29 (Crawled : 18:00) - biospace.com/
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: -1.87%
PFE | News A | $26.32 0.23% 4.4M
|
Health Technology
|
| O: 1.35%
H: 0.15%
C: -2.33%
JNJ | News | $148.24 -0.59% 1.6M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
fda approval hiv order
ViiV Healthcare Announces US FDA Approval of Cabenuva (cabotegravir, rilpivirine) for Use Every Two Months, Expanding the Label of the First and Only Complete Long-Acting HIV Treatment
Published: 2022-02-01 (Crawled : 14:30) - biospace.com/
PFE | News A | $26.32 0.23% 4.4M
|
Health Technology
|
| O: 0.09%
H: 0.8%
C: 0.63%
JNJ | News | $148.24 -0.59% 1.6M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: 0.0%
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: 0.45%
H: 0.53%
C: 0.42%
treatment fda health fda approval thc approval hiv
GSK receives FDA accelerated approval for JEMPERLI (dostarlimab-gxly) for adult patients with mismatch repair-deficient (dMMR) recurrent or advanced solid tumors
Published: 2021-08-17 (Crawled : 21:00) - prnewswire.com
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: 0.17%
H: 0.66%
C: -0.59%
fda solid tumors approval dostarlimab
FDA grants accelerated approval for GSK's JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancer
Published: 2021-04-22 (Crawled : 21:00) - biospace.com/
GSK | News | $40.865 0.68% 320K
|
Health Technology
|
| O: -1.15%
H: 0.36%
C: -0.34%
fda women cancer trial approval granted grant dostarlimab
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.46 96.8% 28M
|
Finance
EDBL | News | $6.94 84.57% 1.4M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.